United States v. Superior Care Pharmacy

District Court, S.D. California·Decided January 15, 2025·No. 3:18-cv-01002·Unknown

Opinion

UNITED STATES OF AMERICA, Case No. 18-cv-1002-MMA-MSB ex rel. SARAH DUNTSCH, ORDER DENYING DEFENDANT Plaintiff, DAVID WALROD’S MOTION TO v. DISMISS

SUPERIOR CARE PHARMACY, et al., [Doc. No. 81] Defendants. On September 16, 2024, the United States of America filed a first amended intervenor complaint against Superior Care Pharmacy, Inc., Derek Ishaque, David Walrod, and Justus Benjamin alleging, among other things, violations of the False Claims Act, 31 U.S.C. § 3729 et seq., and the Controlled Substances Act, 21 U.S.C. § 801 et seq. Doc. No. 76 (“FAC”). On September 30, 2024, Defendant David Walrod filed a motion to dismiss. Doc. No. 81. The government filed a response in opposition to Walrod’s motion, to which Walrod replied. Doc. Nos. 83, 85. The Court found this matter suitable for determination on the papers and without oral argument pursuant to Civil Local Rule 7.1.d.1. See Doc. No. 86. For the reasons set forth below, the Court DENIES Walrod’s motion to dismiss. The core factual allegations as alleged in the initial intervenor complaint, Doc. No. 34, remain largely unchanged. In short, Superior Care Pharmacy, Inc. (“SCP”) provides pharmacy services to skilled nursing facilities in San Diego County. FAC2 ¶¶ 2, 19. Defendants Ishaque, Walrod, and Benjamin were SCP’s principals during the relevant events and time period. Id. ¶¶ 20–22. Generally speaking, the government alleges that Defendants defrauded the United States of millions of dollars by submitting false claims to Medicare and TRICARE. Id. ¶ 7–8. Additionally, the government alleges that when a search warrant was executed at SCP’s premises in 2023, 184,635 controlled substances were missing. Id. ¶ 168. As a result, the government brings seven claims: (1) presentation of false claims in violation of the False Claims Act (“FCA”), 31 U.S.C. § 3729(a)(1)(A), against SCP and Ishaque; (2) using false statements to get false claims paid in violation of the FCA, id. § 3729(a)(1)(B), against SCP and Ishaque; (3 & 4) failure to make, keep, or furnish records in violation of the Controlled Substances Act (“CSA”), 21 U.S.C. § 842(a)(5), against SCP, Ishaque, and Benjamin; (5) fraudulent transfer in violation of the Federal Debt Collection Procedures Act (“FDCPA”), 28 U.S.C. § 3304(b)(1)(A), against all Defendants; (6) payment by mistake against all Defendants; and (7) unjust enrichment against all Defendants. A Rule3 12(b)(6) motion tests the legal sufficiency of the claims made in the complaint. See Navarro v. Block, 250 F.3d 729, 732 (9th Cir. 2001). A pleading must contain “a short and plain statement of the claim showing that the pleader is entitled to relief,” Fed. R. Civ. P. 8(a)(2), such that the defendant is provided “fair notice of what the 1 Because this matter is before the Court on a motion to dismiss, the Court accepts as true the allegations set forth in the Complaint. See Hosp. Bldg. Co. v. Trs. Of Rex Hosp., 425 U.S. 738, 740 (1976). 2 The government neglected to file a redline version of their amended pleading as is required by the Civil Local Rules. CivLR 15.1.c. The Court cautions the government that any further noncompliant filings may be rejected. . . . claim is and the grounds upon which it rests.” Bell Atl. Corp. v. Twombly, 550 U.S. 544, 555 (2007) (quoting Conley v. Gibson, 355 U.S. 41, 47 (1957)). However, plaintiffs must also plead “enough facts to state a claim to relief that is plausible on its face.” Fed. R. Civ. P. 12(b)(6); Twombly, 550 U.S. at 570. The plausibility standard demands more than “a formulaic recitation of the elements of a cause of action,” or “naked assertions devoid of further factual enhancement.” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (internal quotation marks omitted). Instead, the complaint “must contain allegations of underlying facts sufficient to give fair notice and to enable the opposing party to defend itself effectively.” Starr v. Baca, 652 F.3d 1202, 1216 (9th Cir. 2011). In reviewing a motion to dismiss under Rule 12(b)(6), courts must assume the truth of all factual allegations and must construe them in the light most favorable to the nonmoving party. See Cahill v. Liberty Mut. Ins. Co., 80 F.3d 336, 337–38 (9th Cir. 1996). A court need not take legal conclusions as true merely because they are cast in the form of factual allegations. See Roberts v. Corrothers, 812 F.2d 1173, 1177 (9th Cir. 1987). Similarly, “conclusory allegations of law and unwarranted inferences are not sufficient to defeat a motion to dismiss.” Pareto v. FDIC, 139 F.3d 696, 699 (9th Cir. 1998). The Court previously issued an Order granting in part Defendants Walrod’s and Benjamin’s motions to dismiss the initial intervenor complaint. Doc. No. 64. The Court incorporates that Order by reference. Relevant here, the Court denied their requests to dismiss Claim 5 for violation of the FDCPA, finding that the government had adequately pleaded that SCP’s transfers to Walrod and Benjamin were fraudulent. Id. at 9–10, 13– 14. However, the Court dismissed Claims 6 and 7, for payment by mistake and unjust enrichment, based upon the government’s failure to plead the applicable law, id. at 14, as well as the government’s failure to plead Walrod’s involvement in the double-billing fraud with particularity as is required under Rule 9(b), id. at 9. Walrod now moves to dismiss Claims 5, 6, and 7. See Doc. No. 81. A. Claim 5 – Federal Debt Collection Procedures Act The government’s fifth claim is for violation of the FDCPA. As the Court previously explained, Doc. No. 64 at 13, the FDCPA includes a fraudulent transfer provision, which allows the government to void a fraudulent transfer by a debtor owing a debt to the United States. United States SBA v. Bensal, 853 F.3d 992, 996 (9th Cir. 2017). In particular, the FDCPA provides that “a transfer made or obligation incurred by a debtor is fraudulent as to a debt to the United States, whether such debt arises before or after the transfer is made or the obligation is incurred, if the debtor makes the transfer or incurs the obligation . . . with actual intent to hinder, delay, or defraud a creditor.” 28 U.S.C. § 3304(b)(1)(A). The Court has already determined that the government’s allegations are sufficient to state an FDCPA fraudulent transfer claim against Walrod. Doc. No. 64 at 10, 13–14. The Court previously described the alleged fraudulent transfer. Id. at 9–

Free access — add to your briefcase to read the full text and ask questions with AI

United States v. Superior Care Pharmacy, (S.D. Cal. 2025).

United States v. Superior Care Pharmacy (United States v. Superior Care Pharmacy) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Conley v. Gibson
355 U.S. 41 (Supreme Court, 1957)
Hospital Building Co. v. Trustees of Rex Hospital
425 U.S. 738 (Supreme Court, 1976)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
E. W. Bliss Company v. United States
426 F.2d 12 (Sixth Circuit, 1970)
United States v. Lennard L. Mead
426 F.2d 118 (Ninth Circuit, 1970)
Navarro v. Block
250 F.3d 729 (Ninth Circuit, 2001)
Starr v. Baca
652 F.3d 1202 (Ninth Circuit, 2011)
Roberts v. Corrothers
812 F.2d 1173 (Ninth Circuit, 1987)